Source: Annual Congress 2007 - PG13 - Outcome measures of clinical trials for new drugs for respiratory disease



Rating:

Share or cite this content

Citations should be made in the following way:
A. Agusti (Palma De Mallorca, Spain). Defining outcomes and markers. Annual Congress 2007 - PG13 - Outcome measures of clinical trials for new drugs for respiratory disease

Member's Comments

No comment yet.

Related content which might interest you: Markers of asthma outcome Source: Annual Congress 2007 - Traditional and novel approaches to assess and achieve asthma control Year: 2007 COPD biomarkers and phenotypes: opportunities for better outcomes with precision imaging Source: Eur Respir J, 52 (5) 1801570; 10.1183/13993003.01570-2018 Year: 2018 Identifying tools to investigate outcomes following an exacerbation of COPD Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019 Determining the best diagnostic biomarker for sepsis and prognosis assessment Source: Annual Congress 2012 - Infections and sepsis in the ICU Year: 2012 Definition and outcome Source: Respiratory Failure and Mechanical Ventilation Conference 2020 Year: 2020 Independent prognostic factors and prognostic classifications: how can we predict survival on the basis of clinical, pathological and routine biological factors? Source: Annual Congress 2011 - Prognostic and predictive factors in lung cancer Year: 2011 Surrogate outcome measures Source: Research Seminar 2012 - Preparing for the first early pulmonary intervention studies in infants and preschool childrenwith Cystic Fibrosis Year: 2012 The impact of patient characteristics on the Minimal Clinically Important Difference of COPD health status tools Source: International Congress 2018 – Respiratory epidemiology: from COPD to factors that associate with lung function and infections Year: 2018 Which traits to target in asthma? Importance of treatable traits varies depending on desired outcome Source: International Congress 2019 – Asthma treatment: novel insights from clinical studies Year: 2019 COPD: implementing biomarkers to improve prognosis Source: Virtual Congress 2021 – Clinical year in review Year: 2021 Applicability of pulmonary rehabilitation in primary care: critical success factors, use of patient reported outcomes and consequences of population differences Source: Annual Congress 2011 - Primary Care Day I: Effective disease- and self-management in primary care Year: 2011 Clustering of adherence variability metrics and clinical outcomes in asthma Source: International Congress 2018 – Clinical determinants of asthma and biomarkers Year: 2018 Comparative characteristics of inflammatory markers depending on treatment approaches in brittle asthma Source: Eur Respir J 2006; 28: Suppl. 50, 313s Year: 2006 Clinical markers of asthma outcome in adolescents Source: Eur Respir J 2006; 28: Suppl. 50, 254s Year: 2006 Asthma-associated factors - Potential predictive markers for patients stratification, personalized treatments and prevention Source: International Congress 2016 – Asthma points to ponder Year: 2016 Significant parameters in CBC profiles for expecting outcomes of COPD Source: Virtual Congress 2020 – Diagnosis and management of COPD Year: 2020 Plasma metabolomic signature in COPD patients: Associations to proteomic profile and clinical outcomes Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Are biological markers correlated with nutritional status in stable COPD? Source: Eur Respir J 2006; 28: Suppl. 50, 163s Year: 2006